Objectives: To determine whether the minimum clinically significant difference (MCSD) in visual analogue scale (VAS) pain score varies with age, gender, education level and cause of pain (trauma versus non-trauma) in Chinese patients. Methods: This was a prospective descriptive study of local Chinese patients 15 years of age or older who presented with pain to the accident & emergency department. On presentation, patients were asked to indicate their current pain severity with a single mark through a standard 100-mm visual analogue scale. Then they would be offered an analgesic for pain-relief. After 30-45 minutes, the patients were asked to give a verbal categorical rating of their pain as 'a lot better', 'a little better', 'much the same', 'a little worse', or 'much worse' and to mark the level of pain on a VAS of the same type as used previously. The MCSD in VAS pain score was defined as the mean difference between the current and preceding scores when the subject reported 'a little worse' or 'a little better' in pain. Data were compared based on gender, age, education level, and traumatic versus non-traumatic causes of pain. Results: 186 patients were enrolled in the study, yielding 77 evaluable comparisons where pain was rated as 'a little better' or 'a little worse'. Overall, the MCSD in VAS pain score in the group was 17 mm (95%CI 13.6 mm to 20.6 mm). There were statistically significant differences between the MCSD in VAS pain score between genders and causes of pain (trauma versus non-trauma). Conclusions: The MCSD in VAS pain scores was found to be 17 mm. There was significant differences in MCSD in VAS pain score in different genders and between trauma and non-trauma cases. (Hong Kong j.emerg.med. 2009;16:233-236 
Study population
A consecutive sample was chosen from June to July 2007. Chinese patients presenting to the A&E with pain were eligible for entry into the study. Exclusion criteria were age less than 15 years, inability to understand the questions in Cantonese or English, inability to mark a VAS and altered level of consciousness, including intoxication.
Measurements
Data collection was done by the attending doctors with a specially designed data sheet with two sides. The demographic data collected included age, gender education level and cause of pain (trauma or nontrauma). On presentation, patients were asked to indicate their current pain severity with a single mark through a standard non-hatched 100-mm visual analogue scale. Then they would be offered an analgesic for pain-relief. After 30-45 minutes, the patients were asked to give a verbal categorical rating of their pain as 'a lot better', 'a little better', 'much the same', 'a little worse', or 'much worse' and to mark the level of pain on a VAS of the same type as used previously on the back of the sheet without looking at their previous markings.
The choice of analgesic was not standardised in order not to alter the daily management of our patients. This was an ethical consideration and the choice of analgesic was not a concern in this study.
Introduction
Pain management is one of the challenges that we face every day in the practice of emergency medicine. To assess the quality of current pain management efforts and to evaluate new pain management techniques, the severity of pain must be quantified so that the results can be analysed by statistical methods. The visual analogue scale (VAS) is commonly used to evaluate the severity of acute pain in the emergency setting. Being a one-dimensional scale, it is not only easy to use, but also has the advantage of being reproducible and sensitive to treatment effects. In addition, the data derived can be analysed using parametric statistical techniques. [1] [2] [3] However, there may be a tendency to overestimate the clinical importance of small differences in scores that reach statistical significance. To judge whether one treatment is superior to another, statistical significance is a necessary requirement, but it is not necessarily the same as clinical significance. 1 In pain research, it would be useful to determine the minimum clinically significant difference (MCSD) measured in VAS pain scores, and whether the difference is the same for different age, gender, cause of pain and education level groups. [4] [5] [6] This is the first study conducted on this topic in the local Chinese population.
Method

Study design and setting
This prospective, descriptive study was conducted in the accident and emergency department (A&E) of a district hospital in Hong Kong with a daily attendance around 400 persons. 
Data analysis
The data were analysed using the SPSS version 12.0 software (SPSS Inc, Chicago, IL, USA). Independent t-tests and ANOVA were used when appropriate.
Ethical consideration
The data collection imposed no addition intervention to the patients and did not alter conventional patient management. So we did not apply for ethical approval. All the data collected will be kept confidential and will not be used for other purposes. They will be kept for three years by the first and second authors and will be destroyed afterwards.
Results
A total of 186 subjects were enrolled in the study. However, 4 were withdrawn from analysis due to inadequate documentation and 24 refused analgesic and were excluded, resulting in 158 subjects completed the study. Of the 158 subjects, the comparison of interest was those with pain categorized as 'a little better' or 'a little worse'. There were 77 meeting the inclusion criteria, with 10 reporting 'a little worse'. Those who reported 'a little worse' were handled by their attending doctors accordingly and this study did not alter their clinical management.
The mean VAS score before analgesic was 65 mm and the mean VAS score after analgesic was 48 mm. The MCSD in VAS scores was 17 mm (95% CI, 13.6 mm -20.6 mm). Age, gender, education level and trauma versus non-trauma were variables entered for multivariate analysis.
The study group comprised 48 males and 29 females. The MCSD for males was 21.5 mm (95%CI, 17.3 mm-25.7 mm), and the MCSD for females was 9.1 mm (95% CI, 3.9 mm-14.3 mm). There was statistically significant difference when evaluated by multivariate analysis (p<0.001, ANOVA).
The cause of pain was classified as trauma or nontrauma. There were 28 subjects in the trauma group, with MCSD 10 mm (95%CI, 5.1 mm-14.9 mm).
There were 49 subjects in the non-trauma group, with MCSD 21.1 mm (95%CI, 16.8 mm-25.4 mm). There was statistically significant difference between these scores (p=0.002, ANOVA).
The education level of the subjects was categorized as 'up to Primary 6', 'up to middle school Form 5' and 'above Form 5'. There were 23 subjects in the 'up to Primary 6' group with MCSD 9.8 mm (95% CI 4.7 mm-14.9 mm); 36 subjects in the 'up to middle school Form 5' group with MCSD 17.9 mm (95% CI 14.1 mm-21.7 mm) and 18 subjects in the 'above Form 5' group with MCSD 24.5 mm (95% CI 14.5 mm-34.5 mm). There were no statistically significant differences between these scores on univariate and multivariate analyses (t-test and ANOVA). But interestingly, there was a trend showing higher educational level had a larger MCSD (Figure 1 ).
The age range was 15 to 87 years, with a mean age of 49 years. The MCSD for the age group <50 years old was 20.9 mm (95%CI 15.8 mm-26.0 mm), and MCSD for the age group ≥50 years old was 12.7 mm (95% CI 8.4 mm-17.0 mm). There was no statistically significant difference between these groups (t-test and ANOVA).
The schematic diagram of MCSDs of all the subjects and various subgroups are shown in Figure 1 . 
Discussion
In this study, it was found that the minimum clinically significant difference in VAS pain scores was 17 mm (95% CI, 13.6 mm-20.6 mm). This finding could help in the assessment of the quality of the treatment of pain and in the interpretation of the results in studies comparing pain management strategies. VAS pain score differences of less than 17 mm are unlikely to represent a clinically significant difference in pain experience for patients.
There is little research correlating changes in VAS pain scores with clinical changes in pain experience by patients in the A&E setting. A previous study done by Kelly found that the MCSD in VAS pain scores to be 9 mm (95%CI, 6 mm -13 mm); and it was not affected by age, gender or the cause of pain. 4 Studies using similar methodology by Todd et al 7 and Gallagher et al 8 found the MCSD in VAS pain scores to be 13 mm (95%CI, 10 mm-17 mm). The mean VAS score in our study (before analgesic) was 65 mm, which is on the middle to high end of the VAS scale. A study by Bird et al found that patients with greater pain require a greater change in VAS score to achieve clinically significant pain relief, 9 which could explain why our finding of MCSD was higher than those in previous studies. In our study, the MCSD was found to be 10 mm in the trauma group of patients, which is consistent with the finding of MCSD of 13 mm by Todd et al in this group of patients. 7 In this study, it was found that the cause of pain (trauma versus non-trauma) resulted in different MCSD in VAS pain score. Another interesting finding is the difference in MCSD between males and females. This difference was not significant in other studies. It could be a local characteristic that needs to be further validated by more studies in similar settings. The experience of pain is a complex phenomenon, which is influenced by a number of factors, including physical, psychological and environmental factors. 4, 6 In the experience of trauma, the subject may have different factors affecting his pain response. The lower MCSD observed in the trauma group may signify that a lesser change in VAS pain score is expected to have clinical significance in pain management in this group of patients. It is possible that different causes of pain might have different MCSD, for example, the MCSD for renal colic might be different from that of fractured femur. Further studies would be necessary to investigate the validity of MCSD in various settings. This study is limited by the small sample size obtained. Further studies are needed to establish the MCSD in VAS pain score for different causes. It would also be useful to find out whether different groups of patients have different expectations in pain management, and whether there is any difference in their sensitivity of pain perception.
Conclusion
This study found the minimum clinically significant difference in VAS pain score to be 17 mm (95% CI, 13.6 mm-20.6 mm). Differences of less than this amount, even if statistically significant, are unlikely to be of clinical significance. There are significant differences in MCSD in VAS pain score between genders and between groups of trauma and non-trauma patients.
